CMV pp65-specific T cell adoptive immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CMV pp65-specific T cell adoptive immunotherapy, covering 2012-11-12 to 2012-11-12. Get the full timeline:
Most recent: Clinical Trial Update: CMV pp65 Specific T Cell Adoptive Immunotherapy in Allogeneic Stem Cell Transplantation for Malignant Disease [Phase 1]